About US
Contact us
>>Back
Warner Chilcott announces new FDA PDUFA date of October 24, 2010 for Actonel
- Publisher：
- Publication：2010/7/19
Warner Chilcott plc (Nasdaq: WCRX) announced today that it has received a communication from the U.S. Food & Drug Administration (FDA) related to its next generation Actonel® product (risedronate sodium) delayed-release tablets extending the Prescription Drug User Fee Act (PDUFA) date by three months to allow sufficient time to review additional information solicited by the FDA and previously provided by the Company. The new PDUFA date is October 24, 2010.
SOURCE Warner Chilcott plc